Mahickra Chemicals Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Mahickra Chemicals.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	19.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

Jan 30

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Jan 19

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Jun 14

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Apr 04

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Feb 27

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Feb 06

How Does Mahickra Chemicals Limited (NSE:MAHICKRA) Stand Up To These Simple Dividend Safety Checks?

Jan 31

Should You Take Comfort From Insider Transactions At Mahickra Chemicals Limited (NSE:MAHICKRA)?

Jan 04

Mahickra Chemicals Limited's (NSE:MAHICKRA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 29

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Mahickra Chemicals no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:MAHICKRA - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	742	11	-11	-4	N/A
12/31/2023	802	16	-26	-19	N/A
9/30/2023	863	22	-42	-35	N/A
6/30/2023	958	27	-14	-6	N/A
3/31/2023	1,054	33	14	23	N/A
12/31/2022	1,115	33	N/A	N/A	N/A
9/30/2022	1,176	33	32	43	N/A
6/30/2022	1,113	33	26	38	N/A
3/31/2022	1,049	33	19	32	N/A
12/31/2021	1,013	35	N/A	N/A	N/A
9/30/2021	976	37	N/A	N/A	N/A
6/30/2021	931	34	N/A	N/A	N/A
3/31/2021	886	31	-31	-25	N/A
12/31/2020	849	27	N/A	N/A	N/A
9/30/2020	813	23	N/A	N/A	N/A
6/30/2020	889	26	N/A	N/A	N/A
3/31/2020	964	30	-58	-35	N/A
12/31/2019	937	28	N/A	N/A	N/A
9/30/2019	909	26	N/A	N/A	N/A
6/30/2019	860	23	N/A	N/A	N/A
3/31/2019	812	20	-42	-42	N/A
12/31/2018	400	23	N/A	N/A	N/A
3/31/2018	197	7	-112	-112	N/A
3/31/2017	414	4	N/A	-2	N/A
3/31/2016	340	2	N/A	1	N/A
3/31/2015	422	1	N/A	7	N/A
3/31/2014	431	2	N/A	-17	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de MAHICKRA es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de MAHICKRA crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de MAHICKRA crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de MAHICKRA crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de MAHICKRA crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de MAHICKRA se prevé que sea elevada dentro de 3 años.

Mahickra Chemicals Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Full year 2024 earnings released: EPS: ₹1.32 (vs ₹4.05 in FY 2023)

Chairman & MD recently bought ₹1.3m worth of stock

New minor risk - Share price stability

New minor risk - Share price stability

Chairman & MD recently bought ₹931k worth of stock

Investor sentiment improves as stock rises 21%

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Whole-Time Director recently bought ₹157k worth of stock

First half 2024 earnings released: EPS: ₹0.60 (vs ₹1.95 in 1H 2023)

New major risk - Financial position

Whole-Time Director recently bought ₹500k worth of stock

Mahickra Chemicals Limited, Annual General Meeting, Aug 29, 2023

Chairman & MD recently bought ₹124k worth of stock

New minor risk - Share price stability

Chairman & MD recently bought ₹251k worth of stock

Whole-Time Director recently bought ₹125k worth of stock

Chairman & MD recently bought ₹134k worth of stock

Chairman & MD recently bought ₹148k worth of stock

Whole-Time Director recently bought ₹148k worth of stock

Investor sentiment improves as stock rises 18%

Chairman & MD recently bought ₹127k worth of stock

Chairman & MD recently bought ₹368k worth of stock

Chairman & MD recently bought ₹111k worth of stock

Chairman & MD recently bought ₹112k worth of stock

First half 2023 earnings released: EPS: ₹1.95 (vs ₹2.05 in 1H 2022)

Whole-Time Director recently bought ₹214k worth of stock

Whole-Time Director recently bought ₹100k worth of stock

Whole-Time Director recently bought ₹106k worth of stock

Whole-Time Director recently bought ₹216k worth of stock

Whole-Time Director recently bought ₹109k worth of stock

Chairman & MD recently bought ₹214k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Full year 2022 earnings released: EPS: ₹4.12 (vs ₹3.83 in FY 2021)

Insufficient new directors

Whole-Time Director recently bought ₹118k worth of stock

Chairman & MD recently bought ₹373k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

Whole-Time Director recently bought ₹127k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Chairman & MD recently bought ₹121k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹119k worth of stock

Chairman & MD recently bought ₹120k worth of stock

First half 2022 earnings released

Chairman & MD recently bought ₹119k worth of stock

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹129k worth of stock

Chairman & MD recently bought ₹131k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

New 90-day low: ₹77.10

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Chairman & MD recently bought ₹121k worth of stock

New 90-day low: ₹78.45

How Does Mahickra Chemicals Limited (NSE:MAHICKRA) Stand Up To These Simple Dividend Safety Checks?

Should You Take Comfort From Insider Transactions At Mahickra Chemicals Limited (NSE:MAHICKRA)?

Mahickra Chemicals Limited's (NSE:MAHICKRA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

New 90-day high: ₹84.25

Chairman & MD recently bought ₹113k worth of stock

New 90-day high: ₹80.00

Whole-Time Director recently bought ₹108k worth of stock

Chairman & MD recently bought ₹107k worth of stock

Whole-Time Director recently bought ₹107k worth of stock

New 90-day high - ₹78.55

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento